Published in NMR Biomed on August 01, 2001
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med (2012) 3.30
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study. J Neurotrauma (2009) 1.39
In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects. J Magn Reson Imaging (2011) 1.36
Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24
Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: application in brain tumors. Magn Reson Med (2011) 1.22
T2 measurement of J-coupled metabolites in the human brain at 3T. NMR Biomed (2011) 1.19
Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla. PLoS One (2010) 1.18
Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T. Magn Reson Med (2008) 1.13
In vivo 1H NMR spectroscopy of the human brain at 9.4 T: initial results. J Magn Reson (2010) 1.12
Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: validation in the cerebellum and brainstem. Magn Reson Med (2010) 1.10
Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T. J Magn Reson Imaging (2008) 1.10
Proton MR spectroscopy of the brain at 3 T: an update. Eur Radiol (2007) 1.06
The optimal MR acquisition strategy for exponential decay constants estimation. Magn Reson Imaging (2008) 1.00
Test-retest reliability and reproducibility of short-echo-time spectroscopic imaging of human brain at 3T. Magn Reson Med (2011) 0.99
Optimized glutamate detection at 3T. J Magn Reson Imaging (2009) 0.99
Resting-state glutamate and GABA concentrations predict task-induced deactivation in the default mode network. J Neurosci (2013) 0.96
Hippocampal glutamate concentration predicts cerebral theta oscillations during cognitive processing. Psychopharmacology (Berl) (2006) 0.96
Measuring the longitudinal relaxation time of GABA in vivo at 3 Tesla. J Magn Reson Imaging (2012) 0.94
Quantitative SENSE-MRSI of the human brain. Magn Reson Imaging (2010) 0.94
A comparative study of short- and long-TE ¹H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors. NMR Biomed (2013) 0.92
In vivo magnetic resonance spectroscopy measurement of gray-matter and white-matter gamma-aminobutyric acid concentration in sensorimotor cortex using a motion-controlled MEGA point-resolved spectroscopy sequence. Magn Reson Imaging (2011) 0.89
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo. NMR Biomed (2012) 0.87
Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis. Radiology (2010) 0.86
Comparison of brain gray and white matter macromolecule resonances at 3 and 7 Tesla. Magn Reson Med (2014) 0.85
Quantification of ethanol methyl (1)H magnetic resonance signal intensity following intravenous ethanol administration in primate brain. Methods (2009) 0.84
In vivo detection of serine in the human brain by proton magnetic resonance spectroscopy (1H-MRS) at 7 Tesla. Magn Reson Med (2009) 0.84
Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review. Top Magn Reson Imaging (2010) 0.84
Magnetic resonance imaging protocols for examination of the neurocranium at 3 T. Eur Radiol (2003) 0.83
Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3 T. Age (Dordr) (2013) 0.82
Absolute quantitation of brain metabolites with respect to heterogeneous tissue compositions in (1)H-MR spectroscopic volumes. MAGMA (2012) 0.82
Robust quantification of contrast agent (CA) concentration with magnetic field correlation (MFC) imaging. Magn Reson Med (2009) 0.82
Anteroposterior hippocampal metabolic heterogeneity: three-dimensional multivoxel proton 1H MR spectroscopic imaging--initial findings. Radiology (2008) 0.82
Measurement of glutathione in human brain at 3T using an improved double quantum filter in vivo. J Magn Reson (2009) 0.80
Applications of chemical shift imaging to marine sciences. Mar Drugs (2010) 0.80
(1)H-MRS of brain metabolites in migraine without aura: absolute quantification using the phantom replacement technique. MAGMA (2010) 0.80
Early metabolic development of posteromedial cortex and thalamus in humans analyzed via in vivo quantitative magnetic resonance spectroscopy. J Comp Neurol (2014) 0.80
Metabolite proton T(2) mapping in the healthy rhesus macaque brain at 3 T. Magn Reson Med (2009) 0.79
Brain metabolites B1-corrected proton T1 mapping in the rhesus macaque at 3 T. Magn Reson Med (2010) 0.79
Automated whole-brain N-acetylaspartate proton MRS quantification. NMR Biomed (2014) 0.79
Whole-brain quantitative mapping of metabolites using short echo three-dimensional proton MRSI. J Magn Reson Imaging (2014) 0.79
In vivo T(2) relaxation time measurement with echo-time averaging. NMR Biomed (2014) 0.79
Detection of 2-hydroxyglutarate in brain tumors by triple-refocusing MR spectroscopy at 3T in vivo. Magn Reson Med (2016) 0.78
Various MRS application tools for Alzheimer disease and mild cognitive impairment. AJNR Am J Neuroradiol (2014) 0.77
Retrospective correction for T1-weighting bias in T2 values obtained with various spectroscopic spin-echo acquisition schemes. Magn Reson Imaging (2009) 0.77
In vivo free induction decay based 3D multivoxel longitudinal hadamard spectroscopic imaging in the human brain at 3 T. Magn Reson Med (2012) 0.77
Reproducibility of phase rotation stimulated echo acquisition mode at 3T in schizophrenia: Emphasis on glutamine. Magn Reson Med (2015) 0.77
Dorsal Anterior Cingulate Lactate and Glutathione Levels in Euthymic Bipolar I Disorder: 1H-MRS Study. Int J Neuropsychopharmacol (2016) 0.77
Human Auditory Cortex Neurochemistry Reflects the Presence and Severity of Tinnitus. J Neurosci (2015) 0.76
Reproducibility of macromolecule suppressed GABA measurement using motion and shim navigated MEGA-SPECIAL with LCModel, jMRUI and GANNET. MAGMA (2016) 0.76
Three-dimensional Hadamard-encoded proton spectroscopic imaging in the human brain using time-cascaded pulses at 3 Tesla. Magn Reson Med (2013) 0.76
Fast water concentration mapping to normalize (1)H MR spectroscopic imaging. MAGMA (2014) 0.76
Quantitative 3.0T MR spectroscopy reveals decreased creatine concentration in the dorsolateral prefrontal cortex of patients with social anxiety disorder. PLoS One (2012) 0.75
Model-based acceleration of look-locker T1 mapping. PLoS One (2015) 0.75
Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia. Schizophr Bull (2015) 0.75
Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder. Mol Psychiatry (2016) 0.75
Magnetic Resonance Spectroscopy in Patients with Insomnia: A Repeated Measurement Study. PLoS One (2016) 0.75
Single-voxel (1)H spectroscopy in the human hippocampus at 3 T using the LASER sequence: characterization of neurochemical profile and reproducibility. NMR Biomed (2015) 0.75
Thalamic metabolic abnormalities in patients with Huntington's disease measured by magnetic resonance spectroscopy. Braz J Med Biol Res (2013) 0.75
In vivo estimation of gamma-aminobutyric acid levels in the neonatal brain. NMR Biomed (2016) 0.75
Implementation of multi-echo-based correlated spectroscopic imaging and pilot findings in human brain and calf muscle. J Magn Reson Imaging (2011) 0.75
Prior-knowledge Fitting of Accelerated Five-dimensional Echo Planar J-resolved Spectroscopic Imaging: Effect of Nonlinear Reconstruction on Quantitation. Sci Rep (2017) 0.75
GABA quantitation using MEGA-PRESS: Regional and hemispheric differences. J Magn Reson Imaging (2016) 0.75
Single spin-echo T2 relaxation times of cerebral metabolites at 14.1 T in the in vivo rat brain. MAGMA (2013) 0.75
Global brain metabolic quantification with whole-head proton MRS at 3 T. NMR Biomed (2017) 0.75
Simultaneous determination of metabolite concentrations, T1 and T2 relaxation times. Magn Reson Med (2017) 0.75
The preparation and execution of self-initiated and externally-triggered movement: a study of event-related fMRI. Neuroimage (2002) 2.01
Fractal analysis: an objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri. Gynecol Oncol (1999) 1.74
Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation (1995) 1.71
Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med (1997) 1.66
A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology (1998) 1.60
High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr (2000) 1.57
Finger somatotopy in human motor cortex. Neuroimage (2001) 1.53
Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol (2001) 1.51
Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model. Clin Exp Allergy (2009) 1.48
Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy. Eur J Endocrinol (1995) 1.45
Fuzzy clustering of gradient-echo functional MRI in the human visual cortex. Part I: reproducibility. J Magn Reson Imaging (1998) 1.42
Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. Magn Reson Med (2009) 1.40
In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? Eur J Radiol (2009) 1.38
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med (2001) 1.32
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology (2001) 1.32
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer (2001) 1.30
Effect of local low-dose thrombolysis on clinical outcome in acute embolic renal artery occlusion. Radiology (1993) 1.27
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg (1996) 1.24
Optimized 3 T EPI of the amygdalae. Neuroimage (2004) 1.23
A hierarchical clustering method for analyzing functional MR images. Magn Reson Imaging (1999) 1.23
1H NMR relaxation times of skeletal muscle metabolites at 3 T. MAGMA (2004) 1.22
Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cell Mol Biol (Noisy-le-grand) (1997) 1.22
Quantification in functional magnetic resonance imaging: fuzzy clustering vs. correlation analysis. Magn Reson Imaging (1998) 1.22
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Ann Oncol (2005) 1.21
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol (2005) 1.18
Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology (2001) 1.17
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes (1999) 1.16
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med (2001) 1.15
Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J Gen Virol (2001) 1.14
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging (2004) 1.13
Fully exploratory network ICA (FENICA) on resting-state fMRI data. J Neurosci Methods (2010) 1.12
Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom (1997) 1.10
Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis (2000) 1.08
Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment. NMR Biomed (2008) 1.07
Dynamic interleaved 1H/31P STEAM MRS at 3 Tesla using a pneumatic force-controlled plantar flexion exercise rig. MAGMA (2005) 1.03
A wavelet-based method for improving signal-to-noise ratio and contrast in MR images. Magn Reson Imaging (2000) 1.03
A comparative study on the frequency of prophages among natural isolates of Salmonella and Escherichia coli with emphasis on generalized transducers. Antonie Van Leeuwenhoek (1998) 1.03
Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions. Eur Radiol (2013) 1.01
Biocontrol of Fusarium head blight: interactions between Trichoderma and mycotoxigenic Fusarium. Microbiology (2011) 1.01
Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla. J Psychiatr Res (1999) 1.01
Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol (2007) 1.01
Evidence for premotor cortex activity during dynamic visuospatial imagery from single-trial functional magnetic resonance imaging and event-related slow cortical potentials. Neuroimage (2001) 0.99
Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell. Apoptosis (2005) 0.99
Gas-phase hydrolysis of proteins and peptides. Anal Biochem (1987) 0.98
Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Eur J Radiol (2007) 0.98
Rescue of recombinant Thogoto virus from cloned cDNA. J Virol (2001) 0.97
Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab (2001) 0.96
Model-free fMRI group analysis using FENICA. Neuroimage (2010) 0.96
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? Eur Radiol (2011) 0.95
PET and SPECT in whiplash syndrome: a new approach to a forgotten brain? J Neurol Neurosurg Psychiatry (1997) 0.95
[Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Schirmerreschaft der Deutschen Gesellschaft for Nuklearmedizin]. Nuklearmedizin (1996) 0.95
High-resolution mapping of human brain metabolites by free induction decay (1)H MRSI at 7 T. NMR Biomed (2011) 0.95
FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med (2001) 0.94
Brain dysfunction during motor activation and corpus callosum alterations in schizophrenia measured by cerebral blood flow and magnetic resonance imaging. Biol Psychiatry (1991) 0.94
Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver. Magn Reson Med (2008) 0.94
Quantification of intensity variations in functional MR images using rotated principal components. Phys Med Biol (1996) 0.93
Reconstruction in the buttock region using the local fasciocutaneous infragluteal (FCI) flap. J Plast Reconstr Aesthet Surg (2008) 0.92
Immunoscintigraphy in intraocular malignant melanoma. Nucl Med Commun (1988) 0.92
The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol (1999) 0.91
CYP24A1 splice variants--implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer. J Steroid Biochem Mol Biol (2010) 0.91
Attributes of heavy vs. occasional marijuana smokers in a college population. Biol Psychiatry (1995) 0.91
Analysis of lymphatic drainage in various forms of leg edema using two compartment lymphoscintigraphy. Lymphology (1998) 0.91
Improvement of presurgical patient evaluation by generation of functional magnetic resonance risk maps. Neurosci Lett (2000) 0.91
Fusion imaging: combined visualization of 3D reconstructed coronary artery tree and 3D myocardial scintigraphic image in coronary artery disease. Int J Card Imaging (1999) 0.91
Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T. Eur Radiol (2013) 0.90
[Iodine 131: biokinetics, radiation exposure and risk assessment with reference to the reactor accident at Chernobyl]. Rofo (1987) 0.90
Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype. Neuropediatrics (2003) 0.90
Functional MRI of the human motor cortex using single-shot, multiple gradient-echo spiral imaging. Magn Reson Imaging (1999) 0.90
Impact of systemic immuno-suppression after solid organ transplantation on allergen-specific responses. Allergy (2010) 0.90
Molecular imaging of cancer: MR spectroscopy and beyond. Eur J Radiol (2010) 0.90
In vivo 31P spectroscopy by fully adiabatic extended image selected in vivo spectroscopy: a comparison between 3 T and 7 T. Magn Reson Med (2011) 0.89
The IL-10R1 S138G loss-of-function allele and ulcerative colitis. Genes Immun (2008) 0.89
Comparing localization of conventional functional magnetic resonance imaging and magnetoencephalography. Eur J Neurosci (1995) 0.88
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma. Eur J Surg Oncol (2004) 0.88
Thogoto virus matrix protein is encoded by a spliced mRNA. J Virol (2000) 0.88
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]. Nuklearmedizin (2007) 0.88
[Procedure guidelines for dynamic renal scintigraphy]. Nuklearmedizin (2004) 0.88
Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology (1995) 0.87
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg (2001) 0.87
Modulation of hypothalamus and amygdalar activation levels with stimulus valence. Neuroimage (2010) 0.85
Pathological cerebral blood flow during motor function in schizophrenic and endogenous depressed patients. Biol Psychiatry (1986) 0.85
IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol (2009) 0.85
A new method to assess the results of instrumentation techniques in the root canal. J Endod (1999) 0.85
Lateral arm flap: analysis of its anatomy and modification using a vascularized fragment of the distal humerus. Clin Anat (2003) 0.84
Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology (2005) 0.84
High-resolution, multiple gradient-echo functional MRI at 1.5 T. Magn Reson Imaging (1999) 0.84
Coil combination of multichannel MRSI data at 7 T: MUSICAL. NMR Biomed (2013) 0.84
Waardenburg syndrome type 2 in a Turkish family: implications for the importance of the pattern of fundus pigmentation. Br J Ophthalmol (2001) 0.84
[Guideline for radioiodine therapy for benign thyroid diseases (version 4)]. Nuklearmedizin (2007) 0.83
Evaluation of transport kinetics in lymphoscintigraphy: follow-up study in patients with transplanted lymphatic vessels. Eur J Nucl Med (1985) 0.83
PET imaging of recurrent medullary thyroid cancer. Nuklearmedizin (1996) 0.83
Co-registration of EEG and MRI data using matching of spline interpolated and MRI-segmented reconstructions of the scalp surface. Brain Topogr (2001) 0.82
PB2 polymerase subunit of Thogoto virus (Orthomyxoviridae family). Arch Virol (1999) 0.82